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ABSTRACT 
In the last 20 years, researchers in the field of Assisted Reproductive Technology 
(ART) have made many advances in formulating media for use in in-vitro fertilization 
procedures. In an effort to improve our in-vitro production (fertilization and 
development), we compared a commercially prepared culture medium (Human Tubal 
Fluid [HTF]; Irvine Scientific, Irvine, CA) to our in-house prepared medium 
(Reproductive Endocrinology and Infertility [REI]). Following positive results in media 
comparison trials using mouse embryos, we performed a similar randomized controlled 
study with the use of oocytes from 77 women (mean age [yrs.] = 33 ± 4.3 [SD]). Overall 
fertilization rates for HTF and REI were 67.3% (376/559) versus 78.9% (471/597) 
respectively (Chi-square; P <0.0001). Using the oocyte as the test unit in a logistic 
model for predicting fertilization, and adjusting for subject (mother) and method of 
insemination (in-vitro fertilization versus intracytoplasmic sperm injection), the odds 
ratio (95%) confidence interval) for REI medium versus HTF medium was 1.8 (1.4, 2.4; P 
< 0.0001). Thus, oocytes cultured in REI medium were more likely to fertilize when 
compared to oocytes cultured in HTF medium. Similar analyses for cell-stage 
development and embryo quality as defined by grade, demonstrated no differences 
between the two media. The increase in the number of fertilized oocytes when using REI 
media led to a larger cohort of embryos from which to select superior embryos at the time 
of transfer. Furthermore, this increase in number of fertilized oocytes provided more 
supernumerary embryos for cryopreservation. 
INTRODUCTION 
The term infertility is generally defined as the inability to conceive after one year of 
normal, regular heterosexual intercourse without the use of any contraception (Seibel, 
1990). Based on a series of nationwide surveys conducted by the National Center for 
Health Statistics, it is estimated that approximately 3.3 million of the 40 million 
cohabitating couples of childbearing age in the United States are infertile (Sher et al., 
1995). Individuals seeking treatment for their infertility often resort to Assisted 
Reproductive Technology (ART). 
While human ART procedures are only slightly more than 25 years old, the concept 
of ART is well over 100 years of age (Steptoe and Edwards, 1978). In the 1890's, Walter 
Heape (1891, cited by Wood and Trounson, 1999) successfully transferred embryos 
between rabbits. He demonstrated the physiological possibility of recovering a pre-
implantation stage embryo from a female animal without hindering development. Since 
this discovery, many others have investigated and advanced the technology essential to 
the development of ART. 
Besides the ova and sperm quality, two other important components involved in an 
ART procedure are incubator environment and the culture medium in which the gametes 
reside. The main elements involved in incubation are temperature, humidity, and gas 
composition. The standard temperature for culturing human embryos is 37°C. It is 
believed that incubator temperatures above 37°C induce poor development and provide 
an environment for irreversible morphological changes (Brinster, 1969). Conversely, 
temperatures below 37°C promote a slowing of development and potentially, 
developmental arrest (Brinster, 1969). 
Humidity is considered important when the culture medium in which the embryos 
reside is not covered with mineral oil to prevent evaporation. When the medium is not 
overlaid with oil, the water in the culture medium will evaporate, resulting in an increase 
of osmotic pressure in the culture medium (Elder and Dale, 2000). 
Many of the modern incubators control for nitrogen (N2), oxygen (02) and carbon 
dioxide (CO2). Considered to be inert, the concentration of N2 varies depending on the 
amount of C02 and 02. Whitten (1956, cited by Brinster, 1969) proved that an eight-cell 
mouse embryo can develop in an atmosphere of 5% C02 and 95% air, however the 
embryo cannot develop in 5% C02 and 95% N2. In contrast, Auerbach and Brinster 
(1968, cited by Brinster, 1969) discovered that a two-cell mouse embryo had a significant 
and quantifiable need for atmospheric 0 2 during the culture period. When the culture 
media was placed in a C02, 0 2 and N2 environment, development of the two-cell mouse 
embryo to the blastocyst stage occurred. 
Also important to the optimization of the incubator environment is the type of buffer 
system employed by the medium. Such a buffer is bicarbonate (HC03), which affects the 
pH of the culture medium. In this case, attention must be paid to the concentration of 
HCO3 in the medium and the gas composition inside the incubator. Brinster (1965, cited 
by Brinster, 1969) reported the optimal pH of an embryo culture medium is 
approximately 7.4. In order to maintain this pH, most culture media used for human 
embryos require 5% C02 in the incubator. By holding the HCO3 concentration constant 
and increasing or decreasing the percentage of C02 in an incubator, media pH will 
respond accordingly. 
Early in in-vitro production (IVP) procedures, embryonic culture medium resembled 
the ionic composition of serum. Whitten (1956, cited by Brinster, 1969) found that when 
Ca2+, Mg2+, and K+ were omitted from the medium, there was no growth of the eight-cell 
mouse embryo. He also reported that development was delayed when phosphate (HPO4) 
was absent from the medium. 
While Brinster found that two-cell mouse embryos could develop to the blastocyst 
stage in medium with an osmolarity between 200 and 354 mOsm, he observed that the 
maximum number of two-cell mouse embryos reached the blastocyst stage when the 
osmolarity of the culture medium was 276 mOsm. The culture medium used by Brinster 
contained those specific ions (Ca2+, Mg2+, and K+) that Whitten found to be essential to 
embryonic development (Brinster, 1969). 
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Drawing on the above knowledge of media building, the purpose of this study is to 
compare our in-house REI culture medium to a standard culture medium to determine 
whether differences in fertilization rate and stage and grade of the resulting embryos can 
be observed. 
MATERIALS AND METHODS 
Patient Population. Data for this study were taken from 77 women undergoing a 
fresh, non-donor IVP procedure in our tertiary care hospital-based ART program. All 
patients, regardless of infertility diagnoses, were included in this analysis unless they 
failed to undergo embryo transfer. 
Our institutional review committee approved this prospective, cohort study, and 
patients signed consent forms indicating awareness that their data might be used to 
monitor and possibly improve methodologies used in ART. 
General Endocrine Information. Ovarian stimulation drugs were administered to 
produce several mature oocytes instead of the single oocyte (egg) that normally 
developed each month. By developing more than the single oocyte, the patient increased 
her chance of becoming pregnant. 
Drugs such as leuprolide acetate (Lupron; TAP Pharmaceuticals, North Chicago, IL) 
were used to suppress the normal ovarian function in order to better control the 
stimulation process. Following the initiation of Lupron, ovarian stimulation drugs, called 
gonadotropins, such as follicle stimulating hormone (FSH; Fertinex, Gonal-F, Serono 
Laboratories, Randolph, MA) and possibly, human menopausal gonadotropin (hMG; 
Repronex, Ferring Pharmaceuticals Inc., White Plains, NJ) were used to stimulate the 
ovaries to produce multiple oocytes. 
Hormone values and follicular size were monitored over the course of the stimulated 
cycle as a means to determine the optimal oocyte harvest time. In general, patients that 
were stimulated for nine to eleven days, had three follicles 16 mm or greater in diameter, 
and had a blood estradiol level between 1,500 and 3,000 pg/mL were injected with 
human chorionic gonadotropin (hCG; Profassi, Serono Laboratories, Randolph, MA). 
Thirty-six hours following hCG injection, oocytes were retrieved transvaginally with a 
specially fitted ultrasound probe. 
Stimulation Protocols. Our patient stimulation protocols have been described 
previously (Nichols et al. 2001). Before their IVP cycle, couples underwent screening 
procedures that included a physical examination, uterine evaluation (saline infusion 
sonohysterogram, hysterosalpingogram or hysteroscopy), basal hormone levels (follicle 
stimulating hormone [FSH], dehydroepiandrosterone sulfate, prolactin, and thyroid 
stimulating hormone), semen analysis and a review of previous stimulations or infertility 
treatment cycles. All women with basal FSH levels < 10 mlU/mL (measured on day 3 of 
the menstrual cycle) and no previous history of poor gonadotropin stimulation or cycle 
cancellation, underwent a standard protocol starting with luteal phase Lupron for pituitary 
suppression. 
The standard protocol included the administration of Lupron (0.5 to 1 mg daily) 
beginning on approximately cycle day 21 of the menstrual cycle preceding gonadotropin 
stimulation. Lupron was decreased to 0.25 or 0.5 mg, respectively, at the start of 
gonadotropins and continued daily until the day of hCG administration. After at least 14 
days of Lupron, FSH, with or without hMG, was initiated on cycle day 2, 3, or 4 
beginning at a dose of 150-450 IU daily. Adjustments were made to gonadotropin 
20 
dosages after at least 4 days and thereafter depending upon follicular sizes and estrogen 
levels. We gave 10,000 IU of hCG intramuscularly, when three follicles, measured by 
transvaginal ultrasound, were > 16mm in diameter. 
Women not undergoing the standard protocol received a modified microdose flare 
protocol. After at least 21 days of oral contraceptives, the women were administered 40 
(J,g of Lupron subcutaneously, twice-daily beginning on the second day of withdrawal 
bleeding. At least 450 IU of gonadotropins were given daily to each woman beginning 
two days after the start of Lupron. As in the standard protocol, the hCG injection was 
administered when there were three follicles > 16 mm in size. 
Oocyte (Egg) Retrieval and Incubation. Thirty-four to 36 hours following hCG 
injection, patients were taken to the operating room where, under mild sedation, 
transvaginal ultrasound harvest of oocytes was performed through the vaginal wall. The 
ultrasound probe emitted high-frequency sound waves that were translated into images of 
the reproductive tract shown on a monitor screen. Once the follicles were visualized, a 
needle was inserted into the follicle and the contents of the follicle (fluid and oocyte) 
were aspirated. 
After retrieval, oocytes were placed into 50 \i\ drops of Human Tubal Fluid (HTF; 
Cat. No. 9962, Irvine Scientific, Santa Ana, CA) or culture media made in our laboratory 
(Reproductive Endocrinology and Infertility; REI). The REI media was a modification of 
the media described by Parrish et al. (1988). The drops were prepared in Falcon #3002 
Petri dishes (Becton-Dickinson Labware, Lincoln Park, NJ) one to three hours prior to 
oocyte retrieval with media that were equilibrated overnight in a 36.7°C incubator 
containing a 5.0% CO2 in air and high (95-100%) relative humidity atmosphere. The 
drops were covered with washed, equilibrated mineral oil (Cat. No. M-8410, Sigma 
Chemical Co., St. Louis, MO). Both culture media were supplemented with a serum 
source. The HTF medium was supplemented with synthetic serum substitute (SSS; Cat. 
No. 99193, Irvine Scientific, Santa Ana, CA) at a concentration of 10% (vol/vol). The 
REI medium was supplemented with human serum albumin (Cat. No. A-1887, Sigma 
Chemical Co., St. Louis, MO) at a concentration of 6 mg/mL. 
Oocyte Insemination and Culture. Fertilization of the oocytes was achieved using 
either co-incubation of the oocytes with 20,000 motile sperm (Johnson and Boone, 2000) 
or by intracytoplasmic sperm injection (ICSI) in which a sperm is injected into the 
cytoplasm of the oocyte (ICSI; Johnson et al. 2004). Those oocytes that fertilized 
remained in their specified culture media until their transfer 72 hours later. Embryo 
quality was assessed on the morning of transfer, with Grade 1 being the best quality and 
Grade 5 being non viable. This system of evaluation was similar to Veeck (1991). 
Determination of Pregnancy. Twelve to 14 days following the embryo transfer, 
patients had blood drawn and assayed for the presence of beta-hCG. A clinical pregnancy 
was defined as the presence of appropriately rising beta-hCG levels and the presence of a 
gestational sac demonstrated by ultrasound 6 to 7 weeks after oocyte retrieval. A 
biochemical pregnancy, defined as an initial positive beta-hCG result that failed to rise 
appropriately and no gestational sac on ultrasound, was reported as a failure to conceive. 
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RESULTS 
Overall, fertilization rates for HTF and REI media were 67.3% (376/559) versus 
78.9% (471/597), respectively (Chi-square P < 0.0001). With the use of the oocyte as the 
test unit in a logistic model to predict fertilization, and adjusting for subject (mother) and 
method of insemination (IVF versus ICSI), the odds ratio (95% confidence interval) for 
REI culture medium versus HTF medium was 1.8 (1.4, 2.4; P < 0.0001). Thus, oocytes 
cultured in REI medium had an increased chance of fertilization when compared to 
oocytes cultured in HTF medium. 
Similar analyses for cell-stage development and embryo quality as defined by grade 
showed no significant differences. Mean cell stages (standard deviation) in the two 
groups were 6.1 (2.1) and 6.2 (2.4) for the REI and HTF groups, respectively (P = 0.6). 
Mean cell grades (standard deviation) in the two groups were 2.3 (1.0) and 2.4 (1.1) for 
the REI and HTF groups, respectively (P > 0.4; 1 = Excellent and 5 = Dead). 
Representative samples of a human oocyte, zygote, four-cell, and eight-cell embryo 
are shown in Figure 1. 
Figure 1. Representative samples of a human oocyte (A), zygote (B), four-cell embryo (C), and eight-
cell embryo (D). 
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DISCUSSION 
In an effort to improve existing IVP success, we developed a new culture medium 
(REI) and compared it to the current, widely-used, HTF media. The REI media 
outperformed the HTF media for fertilization, which resulted in more embryos being 
available for fresh transfer or for a future transfer using frozen/thawed embryos. 
Over the past 10 years, many advances have been made in mammalian embryo 
culture media. Today, ART professionals can make decisions about media based on 
quality control procedures applied during manufacturing, cost effectiveness, and length of 
the shelf life. While exact needs of embryos during early development have not been 
completely defined, stage-specific and chemically distinct medium are now being 
developed for use in IVP programs. These media attempt to recreate the natural in vivo 
environment by taking into consideration modifications in embryo metabolism and 
physiology that transpire during the pre-implantation stage. 
Unfortunately, incubator technology has not changed dramatically over the same 
period of time. The basic dual (CO2 and air) and triple gas (CO2, O2 and N2) incubators 
used in the early days of ART are still used today. Research regarding optimal incubator 
environment for specific medium is virtually nonexistent. It seems that because there has 
been success in fertilization and embryo culture in dual and triple gas incubators, both are 
considered adequate for IVP. Although ART fertilization rates are relatively high, 
insufficient incubation technology may inhibit progress. This area needs further research. 
In conclusion, REI medium provides more embryos for the patient because of the 
increased percentage of fertilized oocytes. This increase in embryo number leads to a 
larger cohort of embryos from which to select superior embryos at the time of the 
transfer. Furthermore, supernumerary embryos can be cryopreserved. Cryopreservation 
provides couples with future embryo transfer attempts without the added risk of another 
stimulated cycle; furthermore, frozen embryo cycles offer a sizable reduction in cost. 
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